DASH trial
Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage


ISRCTN 67038373
Room S/D2108, Stroke Trials Unit
School of Medicine, University of Nottingham
Queen's Medical Centre, Derby Road
Nottingham NG7 2UH, United Kingdom
Serious Adverse Event categories

Show table only     Only expected events / all

DASH SAE sub-categories
(as of 28 Feb 2019 at 15:43 GMT)

* - commonly expected after desmopressin

Cardiovascular
9 * Cardiac failure or pulmonary oedema
1447 * Hypervolemia (fluid overload)
 
Nervous system
30 * Agitation / aggression
25 * Headache
17 * Seizure / convulsions
 
Gastro-intestinal
28 * Abdominal pain
101 * Nausea
142 * Vomiting
1448 * Weight gain
 
Haematological/immunological
437 * Allergic reaction
33 * Anaphylactic reaction
1443 * Angioedema
 
Metabolic/endocrine
1446 * Hyponatremia (low sodium)
 
Musculoskeletal/cutaneous
1409 * Pruritus
116 * Rash